OTCMKTS:MDXG - MiMedx Group Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding MiMedx Group Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $6.74 +0.40 (+6.31 %) (As of 01/20/2020 04:00 PM ET) Add Compare Today's Range$6.30Now: $6.74▼$6.7450-Day Range$3.66MA: $4.84▼$7.5852-Week Range$2.28Now: $6.74▼$7.95Volume228,375 shsAverage Volume236,791 shsMarket Capitalization$746.46 millionP/E RatioN/ADividend YieldN/ABeta0.81 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email MiMedx Group, Inc, a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The company's proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MDXG Previous Symbol CUSIPN/A CIK1376339 Webhttp://www.mimedx.com/ Phone770-651-9100Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares110,750,000Market Cap$746.46 million Next Earnings DateN/A OptionableOptionable Receive MDXG News and Ratings via Email Sign-up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. OTC:MDXG Rates by TradingView MiMedx Group (OTCMKTS:MDXG) Frequently Asked Questions What is MiMedx Group's stock symbol? MiMedx Group trades on the OTCMKTS under the ticker symbol "MDXG." How were MiMedx Group's earnings last quarter? MiMedx Group Inc (OTCMKTS:MDXG) posted its quarterly earnings data on Thursday, October, 26th. The medical equipment provider reported $0.08 earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of $0.08. The medical equipment provider had revenue of $84.60 million for the quarter, compared to the consensus estimate of $84.60 million. The business's revenue was up 31.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.06 earnings per share. View MiMedx Group's Earnings History. Has MiMedx Group been receiving favorable news coverage? News headlines about MDXG stock have been trending extremely negative this week, according to InfoTrie. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. MiMedx Group earned a media sentiment score of -5.0 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for MiMedx Group. Who are some of MiMedx Group's key competitors? Some companies that are related to MiMedx Group include Cantel Medical (CMD), Irhythm Technologies (IRTC), Glaukos (GKOS), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), Cardiovascular Systems (CSII), AtriCure (ATRC), Silk Road Medical (SILK), Atrion (ATRI), Shockwave Medical (SWAV), Tactile Systems Technology (TCMD), Cryolife (CRY), Luminex (LMNX), Axonics Modulation Technologies (AXNX) and Orthofix Medical (OFIX). What other stocks do shareholders of MiMedx Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other MiMedx Group investors own include Hawkins (HWKN), Micron Technology (MU), CA (CA), Opko Health (OPK), Endologix (ELGX), Gilead Sciences (GILD), Allergan (AGN), Alibaba Group (BABA), Broadcom (AVGO) and Exelixis (EXEL). Who are MiMedx Group's key executives? MiMedx Group's management team includes the folowing people: Ms. Alexandra O. Haden, Gen. Counsel and Sec. (Age 43)Mr. David J. Coles, Interim Chief Exec. Officer (Age 53)Mr. Edward J. Borkowski, Interim Chief Financial Officer (Age 60)Dr. Thomas J. Koob, Chief Scientific Officer (Age 69)Mr. Thornton A. Kuntz Jr., Sr. VP of Admin. (Age 64) How do I buy shares of MiMedx Group? Shares of MDXG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is MiMedx Group's stock price today? One share of MDXG stock can currently be purchased for approximately $6.74. How big of a company is MiMedx Group? MiMedx Group has a market capitalization of $746.46 million. View Additional Information About MiMedx Group. What is MiMedx Group's official website? The official website for MiMedx Group is http://www.mimedx.com/. How can I contact MiMedx Group? MiMedx Group's mailing address is 1775 W OAK COMMONS COURT NE, MARIETTA GA, 30062. The medical equipment provider can be reached via phone at 770-651-9100 or via email at [email protected] MarketBeat Community Rating for MiMedx Group (OTCMKTS MDXG)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 415 (Vote Outperform)Underperform Votes: 288 (Vote Underperform)Total Votes: 703MarketBeat's community ratings are surveys of what our community members think about MiMedx Group and other stocks. Vote "Outperform" if you believe MDXG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDXG will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/20/2020 by MarketBeat.com StaffFeatured Article: What are the benefits of investing in REITs?
